172 related articles for article (PubMed ID: 24376822)
1. Utilization of neoadjuvant chemotherapy varies in the treatment of women with invasive breast cancer.
Onitilo AA; Onesti JK; Single RM; Engel JM; James TA; Aiello Bowles EJ; Spencer Feigelson H; Barney T; McCahill LE
PLoS One; 2013; 8(12):e84535. PubMed ID: 24376822
[TBL] [Abstract][Full Text] [Related]
2. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?
Jochelson MS; Lampen-Sachar K; Gibbons G; Dang C; Lake D; Morris EA; Morrow M
Ann Surg Oncol; 2015 May; 22(5):1490-5. PubMed ID: 25777093
[TBL] [Abstract][Full Text] [Related]
3. The impact of neoadjuvant systemic therapy on breast conservation rates in patients with HER2-positive breast cancer: Surgical results from a phase II randomized controlled trial.
Yamaguchi T; Hozumi Y; Sagara Y; Takahashi M; Yoneyama K; Fujisawa T; Osumi S; Akabane H; Nishimura R; Mieno MN; Mukai H
Surg Oncol; 2021 Mar; 36():51-55. PubMed ID: 33310293
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the effect of neoadjuvant chemotherapy on surgical outcomes after breast conserving surgery.
Woeste MR; Bhutiani N; Donaldson M; McMasters KM; Ajkay N
J Surg Oncol; 2021 Feb; 123(2):439-445. PubMed ID: 33259649
[TBL] [Abstract][Full Text] [Related]
5. Contralateral Prophylactic Mastectomy Use After Neoadjuvant Chemotherapy.
Christian N; Zabor EC; Cassidy M; Flynn J; Morrow M; Gemignani ML
Ann Surg Oncol; 2020 Mar; 27(3):743-749. PubMed ID: 31732944
[TBL] [Abstract][Full Text] [Related]
6. The use of contrast-enhanced computed tomography before neoadjuvant chemotherapy to identify patients likely to be treated safely with breast-conserving surgery.
Akashi-Tanaka S; Fukutomi T; Sato N; Iwamoto E; Watanabe T; Katsumata N; Ando M; Miyakawa K; Hasegawa T
Ann Surg; 2004 Feb; 239(2):238-43. PubMed ID: 14745332
[TBL] [Abstract][Full Text] [Related]
7. Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy.
O'Neil DS; Nietz S; Buccimazza I; Singh U; Čačala S; Stopforth LW; Joffe M; Jacobson JS; Neugut AI; Crew KD; Ruff P; Cubasch H
Oncologist; 2019 Jul; 24(7):933-944. PubMed ID: 30518615
[TBL] [Abstract][Full Text] [Related]
8. A prospective trial of preoperative chemotherapy in resectable breast cancer: predictors of breast-conservation therapy feasibility.
Newman LA; Buzdar AU; Singletary SE; Kuerer HM; Buchholz T; Ames FC; Ross MI; Hunt KK
Ann Surg Oncol; 2002 Apr; 9(3):228-34. PubMed ID: 11923128
[TBL] [Abstract][Full Text] [Related]
9. Patterns in the Use of Axillary Operations for Patients with Node-Positive Breast Cancer After Neoadjuvant Chemotherapy: A National Cancer Database (NCDB) Analysis.
Srour MK; Tseng J; Luu M; Alban RF; Giuliano AE; Chung A
Ann Surg Oncol; 2019 Oct; 26(10):3305-3311. PubMed ID: 31342364
[TBL] [Abstract][Full Text] [Related]
10. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
[TBL] [Abstract][Full Text] [Related]
11. Breast conservative surgery after neoadjuvant chemotherapy in breast cancer patients: comparison of two tumor localization methods.
Espinosa-Bravo M; Sao Avilés A; Esgueva A; Córdoba O; Rodriguez J; Cortadellas T; Mendoza C; Salvador R; Xercavins J; Rubio IT
Eur J Surg Oncol; 2011 Dec; 37(12):1038-43. PubMed ID: 21940138
[TBL] [Abstract][Full Text] [Related]
12. Use of neoadjuvant chemotherapy for patients with stage I to III breast cancer in the United States.
Mougalian SS; Soulos PR; Killelea BK; Lannin DR; Abu-Khalaf MM; DiGiovanna MP; Sanft TB; Pusztai L; Gross CP; Chagpar AB
Cancer; 2015 Aug; 121(15):2544-52. PubMed ID: 25902916
[TBL] [Abstract][Full Text] [Related]
13. Impact of age on pathological complete response and locoregional recurrence in locally advanced breast cancer after neoadjuvant chemotherapy.
Chou HH; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Yu MC; Lo YF; Dabora MA; Chang HK; Lin YC; Ueng SH; Chen SC
Biomed J; 2019 Feb; 42(1):66-74. PubMed ID: 30987708
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant Chemotherapy does not Increase Complications in Oncoplastic Breast-Conserving Surgery.
Adamson K; Chavez-MacGregor M; Caudle A; Smith B; Baumann D; Liu J; Schaverien M
Ann Surg Oncol; 2019 Sep; 26(9):2730-2737. PubMed ID: 31037439
[TBL] [Abstract][Full Text] [Related]
15. Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database.
Mazor AM; Mateo AM; Demora L; Sigurdson ER; Handorf E; Daly JM; Aggon AA; Anderson PR; Weiss SE; Bleicher RJ
Breast Cancer Res Treat; 2019 Jan; 173(2):301-311. PubMed ID: 30343456
[TBL] [Abstract][Full Text] [Related]
16. Factors affecting locoregional recurrence in breast cancer patients undergoing surgery following neoadjuvant treatment.
Chou HH; Chung WS; Ding RY; Kuo WL; Yu CC; Tsai HP; Shen SC; Chu CH; Lo YF; Chen SC
BMC Surg; 2021 Mar; 21(1):160. PubMed ID: 33757489
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors in HER2-Positive Primary Breast Cancer Patients Treated Using Neoadjuvant Chemotherapy Plus Trastuzumab.
Fujita N; Enomoto Y; Inakami K; Yanagisawa T; Iguchi C; Aono T; Nomura T; Yamamoto H; Kasugai T; Shiba E
Oncology; 2020; 98(1):35-41. PubMed ID: 31574500
[TBL] [Abstract][Full Text] [Related]
18. Computed tomography reconstruction for evaluating response in axillary lymph nodes of breast cancer after neoadjuvant chemotherapy.
Wang L; Li Y; Li J; Wang T; Xie Y; He Y; Fan Z; Ouyang T
Clin Transl Oncol; 2021 Feb; 23(2):240-245. PubMed ID: 32519177
[TBL] [Abstract][Full Text] [Related]
19. Loco-regional control after neo-adjuvant chemotherapy and conservative treatment for locally advanced breast cancer patients.
Levy A; Borget I; Bahri M; Arnedos M; Rivin E; Vielh P; Balleyguier C; Rimareix F; Bourgier C
Breast J; 2014; 20(4):381-7. PubMed ID: 24890310
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of early failure of neoadjuvant chemotherapy in locally advanced breast cancer.
Choi MK; Park YH; Kil WH; Lee JE; Nam SJ; Ahn JS; Im YH
Cancer Chemother Pharmacol; 2014 Sep; 74(3):521-9. PubMed ID: 25047725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
